AVITA Medical
Update in progressRCEL (NasdaqCM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
AVITA Medical, Inc. and its subsidiaries develop therapeutic acute wound care products with operations in the US, Europe, the UK, Japan, and Australia. Its lead product, the RECELL System, is a cell harvesting device for burn injuries, full-thickness skin defects, and repigmentation of vitiligo. It also offers RECELL GO and GO mini devices, RECALL, preparation kits, and matrices PermeaDerm and Cohealyx. Headquartered in Valencia, California.
Company score
- Sentiment
- 0.06
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.25
- Governance
- 0.03
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.08
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.07
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqCM (NCM)
- LocationUnited States
- CEOMr. Cary G. Vance
- Employees226
- Websiteavitamedical.com
Identifiers
- ISINUS05380C1027
- FIGIBBG00TD18T43
- CUSIP053792107
- CIK0001762303